Cheplapharm Arzneimittel GmbH | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Headlines Articles Press releases Cheplapharm Arzneimittel GmbH

Home
Companies
Cheplapharm Arzneimittel GmbH

BRIEF

published on 11/08/2024 at 10:50, 12 days 23 hours ago

Sebastian Braun Honored as EY Entrepreneur of the Year

Entrepreneurship Family Business CHEPLAPHARM EY Award Sebastian Braun
PRESS RELEASE

published on 11/08/2024 at 10:45, 12 days 23 hours ago

SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR
Sebastian Braun, Chairman of CHEPLAPHARM Group, wins EY Entrepreneur of the Year in 'family business' category. Recognized for outstanding leadership and business growth

Entrepreneurship Business Award EY Entrepreneur Of The Year Sebastian Braun CHEPLAPHARM Group
BRIEF

published on 07/17/2024 at 12:19, 4 months 3 days ago

CHEPLAPHARM Reorganizes Management Team

Pharmaceutical Supply Chain Management Corporate Development CHEPLAPHARM
PRESS RELEASE

published on 07/17/2024 at 12:14, 4 months 3 days ago

CHEPLAPHARM reorganises Management Team
CHEPLAPHARM reorganises Management Team with new appointments and expanded responsibilities, preparing for the future. Artem Gevorkyan joins as Managing Director Corporate Business Development, Karl Lang leads Supply Chain & Logistics, Klaus Köhl leaves company

Management Team Reorganization CHEPLAPHARM Artem Gevorkyan Karl Lang
BRIEF

published on 04/26/2024 at 12:00, 6 months 24 days ago

CHEPLAPHARM Reports Record Revenue and Growth in Financial Year 2023

Pharmaceutical Industry Acquisitions Financial Growth Corporate Bonds CHEPLAPHARM
PRESS RELEASE

published on 04/26/2024 at 11:55, 6 months 24 days ago

CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth
CHEPLAPHARM reports record revenue of €1.5 billion and 17% year-over-year growth in financial year 2023. EBITDA up 14% to €780.5 million with stable 52% margin. Expansion with new affiliates in Japan and Switzerland

EBITDA Revenue Acquisitions Growth CHEPLAPHARM
BRIEF

published on 04/03/2024 at 10:15, 7 months 18 days ago

Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS

Pharmaceutical Industry Managing Director Leadership Change Caroline Jacquin CHEPLAPHARM France SAS
PRESS RELEASE

published on 04/03/2024 at 10:10, 7 months 18 days ago

Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS
Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS, experienced pharmaceutical manager with 25 years in leading positions to lead the French subsidiary. Isabelle Dalle retiring

Pharmaceutical Industry Managing Director Caroline Jacquin CHEPLAPHARM France SAS Isabelle Dalle
PRESS RELEASE

published on 11/06/2023 at 10:03, 1 year ago

CHEPLAPHARM opens presence in Tokyo
PRESS RELEASE

published on 09/21/2023 at 13:41, 1 year 1 month ago

CHEPLAPHARM succesfully places additional notes in a volume of €300m

Accesswire

Published on 11/21/2024 at 10:03, 36 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 39 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 39 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 4 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 14 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 34 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 36 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 38 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 38 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 37 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 19 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 54 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 54 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE